Tumour model

ARPE-19

XenograftIn vitro

Model characteristics

Organism
Human
Tissue of origin
Retina
Pathology
Model type
In vitro, Xenograft
Availability
2 to 3 weeks

Request this model

Tell us about your compound and your endpoints. Our team confirms feasibility, timelines and study design before any commitment.

Related models

Other models sharing the same tissue of origin.

Model
Organism
Tissue of origin
Pathology
Type
Mouse
Retina
SyngeneicIn vitro
Human
Retina
Retinoblastoma
XenograftIn vitro